CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

promising biotech

  1. malmanu
    16,259 Posts.
    lightbulb Created with Sketch. 742
    clock Created with Sketch.
    16/03/11
    23:30
    Post #: 8066094
    Oncology company Chemgenex Pharmaceuticals (CXS) is also on track again with the FDA. The company is expected to resubmit its new drug application in the first half of 2011 for Omapro, for the treatment of chronic myeloid leukaemia




    http://www.asx.com.au/resources/newsletters/investor_update/20110111_9_promising_biotechs.htm
    CXS Price at posting: 44.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
HAR Haranga resource upgrade builds confidence in Saraya uranium project
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.